Form 8-K - Current report:
SEC Accession No. 0001019687-05-000698
Filing Date
2005-03-15
Accepted
2005-03-15 07:59:31
Documents
3
Period of Report
2005-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 titan_8k-031405.htm 8-K 11293
2 titan_8kex99-1.htm EX-99.1 52145
3 GRAPHIC titan-logo.gif GRAPHIC 2003
  Complete submission text file 0001019687-05-000698.txt   67345
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 05680037
SIC: 2836 Biological Products, (No Diagnostic Substances)